Henan company begins production on COVID-19 oral drug

By SHI BAOYIN and ZHENG CAIXIONG | chinadaily.com.cn | Updated: 2022-08-03 20:29
Share
Share - WeChat
Henan Biotech Ltd officially started production of Azvudine, an anti-COVID-19 oral medicine, in Pingdingshan, Central China's Henan province, on Aug 2, 2022. [Photo provided to chinadaily.com.cn]
|<< Previous 1 2 3   
Previous 3/3
Photo

Xi on contributions of workers and care for them

Shenzhou XIX astronauts out of return capsule in good health

Watch it again: Special coverage of Shenzhou XIX crew's return to Earth

Challenging Resolution 2758 will 'inevitably fail'

Milu deer adapt to new home in Tianjin

Foreign visitors impressed by easier sales tax refunds

Top
BACK TO THE TOP
English
中文
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
About China Daily
Advertise on Site
Contact Us
Job Offer
Expat Employment
FOLLOW US